You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Virus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))

Not yet recruiting
  • Ebola Virus Disease
  • rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
  • Kenema, Eastern, Sierra Leone
    Kenema Government Hospital
Aug 7, 2023

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

Respiratory Syncytial Virus Disease in Infants and Toddlers

Not yet recruiting
  • Respiratory Syncytial Virus Infections
    • (no location specified)
    Jul 27, 2023

    Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

    Completed
    • Respiratory Syncytial Virus (RSV)
    • London, United Kingdom
      Pfizer
    Oct 5, 2023

    Seroconversion of Hepatitis c Virus Among CKD on Regular

    Not yet recruiting
    • Hepatitis C Virus
      • (no location specified)
      Oct 25, 2023

      Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)

      Not yet recruiting
      • Respiratory Syncytial Virus Infection
      • (no location specified)
      Oct 6, 2023

      Interaction Between Hepatitis C Virus Infection and Pregnancy

      Enrolling by invitation
      • Hepacivirus
      • Pregnancy
      • HCV infection status
      • Beijing, China
        Beijing Ditan Hospital
      Jun 24, 2023

      Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis
      • Chronic Active Epstein-Barr Virus Infection
      • No intervention
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      May 2, 2023

      Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSV/Flu-01E low dose
      • +2 more
      • Saint Petersburg, Russian Federation
        Smorodintsev Research Institute of Influenza
      Jul 24, 2023

      Chikungunya Virus Infection Trial (VLA1553)

      Not yet recruiting
      • Chikungunya Virus Infection
      • VLA1553
      • (no location specified)
      Aug 31, 2023

      Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

      Not yet recruiting
      • Chronic Hepatitis Delta Virus Infection
      • HH-003(20mg/kg)
      • +2 more
      • (no location specified)
      May 7, 2023

      Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)

      Not yet recruiting
      • Marburg Virus Disease
      • cAd3-Marburg vaccine
      • Placebo
      • Siaya, Kenya
      • +1 more
      Apr 17, 2023

      Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

      Enrolling by invitation
      • Multiple Sclerosis
      • Truvada (tenofovir/emtricitabine)
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jul 14, 2023

      Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge

      Not yet recruiting
      • Dengue
      • Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
      • Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
      • Syracuse, New York
        State University of New York, Upstate Medical University (SUNY-U
      Jul 28, 2023

      Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

      Recruiting
      • Adenovirus Infection
      • +6 more
      • Virus-specific Cytotoxic T-lymphocytes
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 6, 2023

      Epstein Barr Virus Infection in Radiologically Isolated Syndrome

      Recruiting
      • Multiple Sclerosis
      • +2 more
      • NO INTERVENTION
      • Nice, France
        Nice University Hospital
      Apr 3, 2023

      Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

      Recruiting
      • Sarcoma
      • +9 more
      • Recombinant oncolytic herpes simplex virus type 1 (R130)
      • Linyi, Shandong, China
        Linyi Central Hospital
      Jul 25, 2023

      Early Detection of Epstein-Barr Virus Related Disease.

      Active, not recruiting
      • Post-transplant Lymphoproliferative Disorder
      • +8 more
        • Aarhus, Central Region Of Denmark, Denmark
          Aarhus University Hospital
        Dec 12, 2022

        Anal Fissure Among Survivors of COVID-19 Virus Infection.

        Completed
        • Anal Fissure
        • Corona Virus Infection
          • Mansoura, Egypt
            Ahmad
          Feb 22, 2023

          Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

          Recruiting
          • Sarcoma
          • +8 more
          • Recombinant oncolytic herpes simplex virus type 1 (R130)
          • Shanghai, Jiangsu, China
            Xuzhou Second People's Hospital
          May 8, 2023

          Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?

          Recruiting
          • Cervical Cancer
          • +2 more
          • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
          • Shanghai, Shanghai, China
            Shanghai Tenth People's Hospital
          Mar 31, 2023

          Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

          Not yet recruiting
          • Ebola Virus Disease
          • Zabdeno® booster
          • Ervebo® booster
          • Goma, Congo, The Democratic Republic of the
          • +1 more
          Nov 6, 2023

          Influenza Infection Trial (Molnupiravir, Placebo molnupiravir, Placebo oseltamivir)

          Not yet recruiting
          • Influenza Infection
          • (no location specified)
          Apr 5, 2023

          Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

          Recruiting
          • Osteosarcoma
          • +3 more
          • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
          • Xi'an, Shaanxi, China
            Xi'an Honghui Hospital
          May 8, 2023

          Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

          Not yet recruiting
          • Influenza
          • Quadrivalent influenza virus subunit vaccine
          • Quadrivalent split influenza virus vaccine
          • Taizhou, Jiangsu, China
            Ab&b Biotechnology Co., Ltd.JS
          Jan 12, 2023